Genetic algorithm for analysis of mutations in Parkinson's disease
暂无分享,去创建一个
Cassio Pennachin | Lucio Coelho | Francisco Prosdocimi | Rafal Smigrodzki | Ben Goertzel | W. Davis Parker
[1] J. Cooper,et al. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease , 1998, Annals of neurology.
[2] J. Rissanen. Stochastic Complexity and Modeling , 1986 .
[3] Jason P. Sheehan,et al. Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[4] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[5] D. Turnbull,et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA , 1999, Nature Genetics.
[6] Maria Jesus Martin,et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..
[7] Xuhua Xia,et al. Protein structure, neighbor effect, and a new index of amino acid dissimilarities. , 2002, Molecular biology and evolution.
[8] Dominic Thyagarajan,et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease , 2003, Annals of neurology.
[9] David H. Wolpert,et al. On Bias Plus Variance , 1997, Neural Computation.
[10] J. S. Urban Hjorth,et al. Computer Intensive Statistical Methods: Validation, Model Selection, and Bootstrap , 1993 .
[11] David E. Goldberg,et al. Genetic Algorithms in Search Optimization and Machine Learning , 1988 .
[12] Cyril Goutte,et al. Note on Free Lunches and Cross-Validation , 1997, Neural Computation.
[13] R. Davis,et al. Cybrids in Alzheimer's disease: A cellular model of the disease? , 1997, Neurology.
[14] S. T. Buckland,et al. Computer Intensive Statistical Methods: Validation, Model Selection, and Bootstrap , 1993 .
[15] R. Swerdlow,et al. Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.
[16] J. Shao. Linear Model Selection by Cross-validation , 1993 .
[17] Gary E. Gibson,et al. Low mutational burden of individual acquired mitochondrial DNA mutations in brain. , 2001, Genomics.
[18] J. Parks,et al. Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.
[19] Portland Press Ltd. IUPAC-IUB Commission on Biochemical Nomenclature. A one-letter notation for amino acid sequences. Tentative rules. , 1969, The Journal of biological chemistry.
[20] Jean-Pierre Mazat,et al. Mitochondrial threshold effects. , 2003, The Biochemical journal.
[21] William M. Mauck,et al. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson’s disease , 2004, Neurobiology of Aging.
[22] J. Parks,et al. High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging , 2004, Neurobiology of Aging.
[23] John H. Holland,et al. Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .
[24] W. Parker,et al. Cytochrome Oxidase Deficiency in Alzheimer's Disease a , 1991, Annals of the New York Academy of Sciences.
[25] J. Parks,et al. Mitochondrial ND5 mutations in idiopathic Parkinson's disease. , 2005, Biochemical and biophysical research communications.